Drug recall · March 20, 2024
Telmisartan Tablets recall
Why: Failed Stability Specifications: Out of specification for blend uniformity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.
- Lots / codes
Lot #s: SFBG024, SFBG025, Exp. 05/31/2024
- Quantity
- 118,080 bottles
- Company
- Micro Labs Limited, Verna, N/A
- Distribution
- Puerto Rico, TN, RI
- Initiated
- February 9, 2024 · Voluntary: Firm initiated
- Classified
- March 14, 2024
- Reported
- March 20, 2024
- Ended
- June 24, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Telmisartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.